暂无数据
暂无内容
暂无数据
暂无数据
暂无数据
摩根大通维持Hologic增持
摩根大通维持Hologic增持
道琼斯15:52 (美东)
财报电话会议摘要 | Hologic (HOLX.US) 2024 年第二季度财报会议
以下是Hologic, Inc.(HOLX)2024年第二季度财报电话会议记录摘要:财务业绩:Hologic公布的第二季度总收入为10.2亿美元,非公认会计准则每股收益为1.0美元
moomoo AI15:22 (美东) · 电话会议
Hologic, Inc.(纳斯达克股票代码:HOLX)2024年第二季度财报电话会议记录
Yahoo Finance12:40 (美东)
研究快讯:CFRA对Hologic, Inc.的股票保持持有看法
独立研究提供商CFRA已向MT Newswires提供了以下研究警报。CFRA的分析师总结了他们的观点如下:我们将12个月的目标价格上调了5美元
MT Newswires12:30 (美东)
Hologic(HOLX)第二季度收益超出预期,2024 年向上查看
Yahoo Finance12:29 (美东)
摩根大通将Hologic的目标股价从85美元调整至91美元
Capital IQ调查的分析师表示,Hologic(HOLX)的平均跑赢大盘评级,目标股价区间为70美元至95美元。价格:76.17,涨幅:+0.26,变动百分比:+0.34
MT Newswires05/03 11:54 (美东)
FrankieSmilez楼主 : https://abcnews.go.com/Health/fda-advisory-committees-meeting-discuss-counter-birth-control/story?id=99166534
Trytosaveabit : @FrankieSmilez I know this is a old post from you! But I just found it! Hehehe. Would have made me more comfortable with my decision to take a position back on the 18th of July! Hehehe. It worked out nicely but still! Hehehe. I see you also have $Dare Bioscience (DARE.US)$ in this comment! Another I’m swinging! Hope you having a great day? Haven’t heard much from you since early ?
FrankieSmilez楼主 Trytosaveabit: Femy took off today I've been eyeing the news on this sector and it finally gained some traction. I agree Dare is another good one
暂无数据
暂无数据